Case-Based Video Vignettes:
Leukemia
  1. Course List
Chairs
faculty image
Jerald P. Radich, MD
  • Professor of Medicine Clinical Research Division
  • University of Washington School of Medicine
  • Member Fred Hutchinson Cancer Research Center
  • Clinical Research Division Seattle Cancer Care Alliance
  • Seattle, Washington
  • faculty image
    Moshe Talpaz, MD
  • Professor, Department of Internal Medicine, Hematology-Oncology
  • Associate Director for Translation Research
  • University of Michigan Comprehensive Cancer Center
  • Ann Arbor, Michigan
  • This free point-of-care clinical companion focuses on the treatment and management of leukemia - €”including guidance on second-generation tyrosine kinase inhibitors (TKIs) that were recently approved for first-line therapy - through a collection of patient video case vignettes.
  • Evaluate characteristics of tyrosine kinase inhibitor (TKI) therapies and assess factors considered when tailoring treatment to the individual patient in order to improve treatment response and quality of life.
  • Explore the definitions of various response criteria and their role in assessing effectiveness of therapy, identifying patients who have relapsed, and identifying patients at risk for resistance or relapse.
  • Describe challenges surrounding adherence to TKI therapies and strategies to improve patient outcomes.
  • Analyze the role of BCR-ABL mutational analysis and apply the results in clinical practice.
  • Prevent and manage adverse events associated with TKI therapies.
  • Target Audience

    These activities are designed for hematologists, oncologists, physician assistants, nurses, and pharmacists who specialize in and care for patients with CML.

     

    Activity Goal

    The goal of these CME/CE activities is to provide up-to-date information on key issues and management strategies, and real-world patient case-based scenarios that they can utilize in the treatment of patients with CML.